These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 36473988)

  • 1. Targeting redox regulation and autophagy systems in cancer stem cells.
    Khan SU; Rayees S; Sharma P; Malik F
    Clin Exp Med; 2023 Sep; 23(5):1405-1423. PubMed ID: 36473988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
    Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
    Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cells and Their Therapeutic Usage.
    Osum M; Kalkan R
    Adv Exp Med Biol; 2023; 1436():69-85. PubMed ID: 36689167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox Regulation in Cancer Stem Cells.
    Ding S; Li C; Cheng N; Cui X; Xu X; Zhou G
    Oxid Med Cell Longev; 2015; 2015():750798. PubMed ID: 26273424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.
    Celià-Terrassa T; Jolly MK
    Cold Spring Harb Perspect Med; 2020 Jul; 10(7):. PubMed ID: 31570380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
    Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
    Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
    Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
    Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.
    Marcucci F; Ghezzi P; Rumio C
    Mol Cancer; 2017 Jan; 16(1):3. PubMed ID: 28137290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology underlying the robustness of cancer stem cells.
    Yoshida GJ; Saya H
    Regen Ther; 2021 Jun; 17():38-50. PubMed ID: 33869685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Significance of Cancer Stem Cells and Epithelial-Mesenchymal Transition in Metastasis and Anti-Cancer Therapy.
    Liang L; Kaufmann AM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Role of Autophagy in Governing Cellular Dormancy, Metabolic Functions, and Therapeutic Responses of Cancer Stem Cells.
    Tiwari M; Srivastava P; Abbas S; Jegatheesan J; Ranjan A; Sharma S; Maurya VP; Saxena AK; Sharma LK
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
    Kim HM; Haraguchi N; Ishii H; Ohkuma M; Okano M; Mimori K; Eguchi H; Yamamoto H; Nagano H; Sekimoto M; Doki Y; Mori M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S539-48. PubMed ID: 21879266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox regulation of cell state and fate.
    Lee BWL; Ghode P; Ong DST
    Redox Biol; 2019 Jul; 25():101056. PubMed ID: 30509603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses.
    Luo M; Wicha MS
    Semin Radiat Oncol; 2019 Jan; 29(1):42-54. PubMed ID: 30573183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Stemness, Reactive Oxygen Species, and Epithelial-to-Mesenchymal Transition in Model Circulating Tumor Cells.
    Brown SR; Bates JC; Avera AD; Kim Y
    Cells Tissues Organs; 2022; 211(3):282-293. PubMed ID: 34077929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Nimmakayala RK; Leon F; Rachagani S; Rauth S; Nallasamy P; Marimuthu S; Shailendra GK; Chhonker YS; Chugh S; Chirravuri R; Gupta R; Mallya K; Prajapati DR; Lele SM; C Caffrey T; L Grem J; Grandgenett PM; Hollingsworth MA; Murry DJ; Batra SK; Ponnusamy MP
    Oncogene; 2021 Jan; 40(1):215-231. PubMed ID: 33110235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.